abo1105
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 27, 2025 (NCT07289503)
Timeline
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07289542 | Phase 2 | Sep 15, 2025 | Abogen Biosciences Co. Ltd. |
| NCT07289503 | Phase 1 | May 27, 2025 | Abogen Biosciences Co. Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Abogen Biosciences Co. Ltd. | For profit | 2 | 2 | 2 | 2025 |
1 organizations
Page 1 / 1